Chad Pecot, MD (@chadpecot) 's Twitter Profile
Chad Pecot, MD

@chadpecot

Searching for the cure since surviving cancer | Former Half Professor | Creating RNA medicines to tackle cancer’s vices | Potentially sarcastic

ID: 1275552003888906246

linkhttps://unclineberger.org/pecotlab/ calendar_today23-06-2020 22:12:26

1,1K Tweet

1,1K Takipçi

288 Takip Edilen

Cancer Cell (@cancer_cell) 's Twitter Profile Photo
Cancer Cell
@cancer_cell

2 months ago

Online Now: A first-in-class EGFR-directed KRAS G12V selective inhibitor dlvr.it/TLS4CJ

Online Now: A first-in-class EGFR-directed KRAS G12V selective inhibitor dlvr.it/TLS4CJ
UNC Lineberger (@unc_lineberger) 's Twitter Profile Photo
UNC Lineberger
@unc_lineberger

2 months ago

.Chad Pecot, MD, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks. unclineberger.org/news/uniquely-…

Lior Pachter (@lpachter) 's Twitter Profile Photo
Lior Pachter
@lpachter

2 months ago

This week in academia, a not so short🧵... 1. Staff reductions and other cost cutting measures coming to Brown University highereddive.com/news/brown-uni…

Chad Pecot, MD (@chadpecot) 's Twitter Profile Photo
Chad Pecot, MD
@chadpecot

a month ago

Due to a high volume of emails, I am no longer responding. 🫶

OncoDaily (@oncodaily) 's Twitter Profile Photo
OncoDaily
@oncodaily

9 days ago

Development of the First Dual KRAS+MYC Inhibitor - Chad Pecot (Chad Pecot, MD) oncodaily.com/insight/chad-p… #Cancer #Oncology #OncoDaily #Health #Medicine CancerWorld

Development of the First Dual KRAS+MYC Inhibitor - Chad Pecot (<a href="/ChadPecot/">Chad Pecot, MD</a>) oncodaily.com/insight/chad-p… #Cancer #Oncology #OncoDaily #Health #Medicine <a href="/CancerWorldmag/">CancerWorld</a>